ArticleScientific reports2025

Tocilizumab as a targeted immunomodulatory therapy in the management of severe respiratory illnesses: a multicenter cohort study of COVID-19 patients.

Abbas Al Mutair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.